Esteban Masuda

Person

Menlo Park, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
RIP1K inhibitors
- Patent number 12,297,202
- Issue date May 13, 2025
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treatment of COVID-19-associated conditions
- Patent number 12,263,180
- Issue date Apr 1, 2025
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 12,116,354
- Issue date Oct 15, 2024
- RIGEL PHARMACEUTICALS, INC.
- Esteban Masuda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,919,890
- Issue date Mar 5, 2024
- Eli Lilly and Company
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 11,672,791
- Issue date Jun 13, 2023
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1K inhibitors
- Patent number 11,667,643
- Issue date Jun 6, 2023
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for inhibition of the JAK pathway
- Patent number 11,667,611
- Issue date Jun 6, 2023
- Rigel Pharmaceuticals, Inc.
- Ankush Argade
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,472,782
- Issue date Oct 18, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,377,428
- Issue date Jul 5, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,370,765
- Issue date Jun 28, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,370,764
- Issue date Jun 28, 2022
- Rigel Pharmaceuticals. Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 11,332,451
- Issue date May 17, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent number RE48898
- Issue date Jan 25, 2022
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
Information Patent Grant
Compounds and method for treating autoimmune diseases
- Patent number 11,220,496
- Issue date Jan 11, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 11,110,082
- Issue date Sep 7, 2021
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 10,975,064
- Issue date Apr 13, 2021
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
RIP1 inhibitory compounds and methods for making and using the same
- Patent number 10,815,206
- Issue date Oct 27, 2020
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein kinase C inhibitors and uses thereof
- Patent number 10,792,282
- Issue date Oct 6, 2020
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent number 10,577,381
- Issue date Mar 3, 2020
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 10,434,096
- Issue date Oct 8, 2019
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and method for treating autoimmune diseases
- Patent number 10,414,758
- Issue date Sep 17, 2019
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent number 10,357,505
- Issue date Jul 23, 2019
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tyrosine kinase inhibitors
- Patent number 10,130,623
- Issue date Nov 20, 2018
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors and uses thereof
- Patent number 10,005,777
- Issue date Jun 26, 2018
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors and uses thereof
- Patent number 9,913,843
- Issue date Mar 13, 2018
- Rigel Pharmaceuticals, Inc.
- Rao Kolluri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and method for treating autoimmune diseases
- Patent number 9,890,144
- Issue date Feb 13, 2018
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Kinase inhibitors and their uses
- Patent number 9,834,568
- Issue date Dec 5, 2017
- Rigel Pharmaceuticals, Inc.
- Pingyu Ding
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
- Patent number 9,737,554
- Issue date Aug 22, 2017
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein kinase C inhibitors and uses thereof
- Patent number 9,682,976
- Issue date Jun 20, 2017
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for inhibition of the JAK pathway
- Patent number 9,593,082
- Issue date Mar 14, 2017
- Rigel Pharmaceuticals, Inc.
- Ankush Argade
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20250034100
- Publication date Jan 30, 2025
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS AND DOSING REGIMENS FOR RIP1 KINASE INHIBITORS FOR TRE...
- Publication number 20250000872
- Publication date Jan 2, 2025
- Eli Lilly and Company
- Matthew M. ABERNATHY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Irak Inhibitor for Treating Cytokine Release-Related Conditions Ass...
- Publication number 20240382470
- Publication date Nov 21, 2024
- Rigel Pharmaceuticals, Inc.
- Vadim Markovtsov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20240217958
- Publication date Jul 4, 2024
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC INHIBITORS OF IRAK
- Publication number 20230391748
- Publication date Dec 7, 2023
- Rigel Pharmaceuticals, Inc.
- Yan Chen
- G01 - MEASURING TESTING
Information Patent Application
PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS
- Publication number 20230303555
- Publication date Sep 28, 2023
- Rigel Pharmaceuticals, Inc.
- Jack Maung
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1K INHIBITORS
- Publication number 20230265100
- Publication date Aug 24, 2023
- Rigel Pharmaceuticals, Inc.
- Somasekhar BHAMIDIPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20230113841
- Publication date Apr 13, 2023
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20230012676
- Publication date Jan 19, 2023
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
- Publication number 20220218705
- Publication date Jul 14, 2022
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1K INHIBITORS
- Publication number 20220009936
- Publication date Jan 13, 2022
- Rigel Pharmaceuticals, Inc.
- Somasekhar BHMIDIPATI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONS
- Publication number 20210283152
- Publication date Sep 16, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210238153
- Publication date Aug 5, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210214347
- Publication date Jul 15, 2021
- Rigel Pharmaceuticals, Inc.
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210040053
- Publication date Feb 11, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210009537
- Publication date Jan 14, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210002237
- Publication date Jan 7, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20210002236
- Publication date Jan 7, 2021
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20200407332
- Publication date Dec 31, 2020
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PREVENTING AND TREATING THROMBOSIS
- Publication number 20200377518
- Publication date Dec 3, 2020
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES
- Publication number 20200270271
- Publication date Aug 27, 2020
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
- Publication number 20200087293
- Publication date Mar 19, 2020
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20200078348
- Publication date Mar 12, 2020
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
- Publication number 20200016179
- Publication date Jan 16, 2020
- Rigel Pharmaceuticals, Inc.
- Somasekhar Bhamidipati
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20190337907
- Publication date Nov 7, 2019
- Rigel Pharmaceuticals, Inc.
- Esteban Masuda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME
- Publication number 20190337934
- Publication date Nov 7, 2019
- Vanessa Taylor
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
- Publication number 20190292197
- Publication date Sep 26, 2019
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
- Publication number 20190256476
- Publication date Aug 22, 2019
- Rigel Pharmaceuticals, Inc.
- Ankush Argade
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TYROSINE KINASE INHIBITORS
- Publication number 20190099411
- Publication date Apr 4, 2019
- Rigel Pharmaceuticals, Inc.
- Sacha Holland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Protein Kinase C Inhibitors and Uses Thereof
- Publication number 20190060310
- Publication date Feb 28, 2019
- Rigel Pharmaceuticals, Inc.
- Rajinder Singh
- C07 - ORGANIC CHEMISTRY

Esteban Masuda

Person

Patents Grantslast 30 patents

RIP1K inhibitors

Method for treatment of COVID-19-associated conditions

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Tyrosine kinase inhibitors

RIP1K inhibitors

Compositions and methods for inhibition of the JAK pathway

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Compounds and method for treating autoimmune diseases

Tyrosine kinase inhibitors

RIP1 inhibitory compounds and methods for making and using the same

RIP1 inhibitory compounds and methods for making and using the same

Protein kinase C inhibitors and uses thereof

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Tyrosine kinase inhibitors

Compounds and method for treating autoimmune diseases

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Tyrosine kinase inhibitors

Protein kinase C inhibitors and uses thereof

Protein kinase C inhibitors and uses thereof

Compounds and method for treating autoimmune diseases

Kinase inhibitors and their uses

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Protein kinase C inhibitors and uses thereof

Compositions and methods for inhibition of the JAK pathway

Patents Applicationslast 30 patents

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

FORMULATIONS AND DOSING REGIMENS FOR RIP1 KINASE INHIBITORS FOR TRE...

Irak Inhibitor for Treating Cytokine Release-Related Conditions Ass...

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

BICYCLIC INHIBITORS OF IRAK

PYRIMID-2-YL-PYRAZOLE COMPOUNDS AS IRAK INHIBITORS

RIP1K INHIBITORS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

TYROSINE KINASE INHIBITORS

COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES

RIP1K INHIBITORS

METHOD FOR TREATMENT OF COVID-19-ASSOCIATED CONDITIONS

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

METHOD OF PREVENTING AND TREATING THROMBOSIS

PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES

COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES

TYROSINE KINASE INHIBITORS

Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses

COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY

TYROSINE KINASE INHIBITORS

Protein Kinase C Inhibitors and Uses Thereof